Sign in

CIK 0001395937 · Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320162505
Phone
781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$113,716
in 1 filing, $114K under 10b5-1 plans

Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Podlesak Dennis −$114K Director sold 3% of stake

Reading 25 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-03-01 Egros Fabrice Director Sale −10,167 $24.31 $247K 16,074
2021-03-01 Egros Fabrice Director Sale −74 $24.31 $2K 16,000
2021-03-01 Egros Fabrice Director Option exercise · Stock Options (Right to buy) −74 0
2021-03-01 Egros Fabrice Director Option exercise · Stock Options (Right to buy) −10,167 0
2021-02-08 Morrison Briggs Chief Executive Officer Option exercise +35,156 $7.20 $253K 83,492
2021-02-08 Morrison Briggs Chief Executive Officer Sale −35,156 $20.55 $722K 48,336
2021-02-08 Morrison Briggs Chief Executive Officer Option exercise · Stock Options (Right to buy) −35,156 0
2021-02-03 Metzger Michael A President and COO Grant or award · Stock Option (Right to Buy) +160,000 160,000
2021-02-03 Ordentlich Peter Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +80,000 80,000
2021-02-03 Karydas Daphne Chief Financial Officer Grant or award · Stock Option (Right to Buy) +95,000 95,000
2021-02-03 Morrison Briggs Chief Executive Officer Grant or award · Stock Option (Right to Buy) +195,000 195,000
2021-02-03 Meyers Michael L. SVP, Chief Medical Officer Grant or award · Stock Option (Right to Buy) +80,000 80,000
2021-02-03 Podlesak Dennis Director Grant or award +29,333 29,333
2021-02-03 Meury William Director Grant or award +16,000 16,000
2021-02-03 Legault Pierre Director Grant or award +16,000 16,000
2021-02-03 Katkin Keith Director Grant or award +16,000 16,000
2021-02-03 Jarrett Jennifer Director Grant or award +16,000 16,000
2021-02-03 Egros Fabrice Director Grant or award +16,000 16,000
2021-02-01 Metzger Michael A President and COO Option exercise +15,000 $7.20 $108K 32,659
2021-02-01 Metzger Michael A President and COO Sale −15,000 $20.19 $303K 17,659

Page 20 of 25 · 500 trades